The long term impact of atrial fibrillation: closing remarks

31 August 2019 (16:50 - 17:00)

Organised by:

Video

Sign in for access options

Slides

About the speakers

Professor Jean-Pierre Bassand

University Hospital Jean Minjoz, Besancon (France)

Doctor Bernard Gersh

Mayo Clinic, Rochester (United States of America)

6 More presentations in this session

Presentation thumbnail

What have registries taught us? New insights from GARFIELD-AF

Professor A. Kakkar (London, GB)

Presentation thumbnail

Long-term outcomes

Professor D. Atar (Oslo, NO)

Presentation thumbnail

Innovations in risk assessment: an integrated risk tool for stroke, death and bleeding

Professor K. Fox (Edinburgh, GB)

Presentation thumbnail

Changes in antithrombotic therapy after atrial fibrillation diagnosis

Doctor F. Cools (Brasschaat, BE)

Presentation thumbnail

Management of care in atrial fibrillation patients: impact of following guidelines for treatment of atrial fibrillation and comorbid conditions

Professor J. Camm (London, GB)

Access the full session

Session thumbnail

What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF

The Event

ESC Congress 2019

31 August 2019 16:50 CET

You may be interested in

Congress Session

Clinical aspects in atrial fibrillation care

31 March 2025

Congress Presentation

Long-term outcomes in patients with non-valvular atrial fibrillation and left atrial appendage closure in a large UK tertiary centre: 10-year experience

24 April 2021

Congress Presentation

Time investments and questions raised by atrial fibrillation patients following a personalized educational follow-up strategy

29 August 2022

Congress Session

Great Debate: do we really need long-term cardiac rhythm monitoring after embolic stroke of unknown source?

30 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources